Lista de obras - Luigi Maione - Dominio Público Uruguay

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

artículo científico publicado en 2017

Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.

artículo científico publicado en 2017

Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature

artículo científico publicado en 2018

Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry

artículo científico publicado en 2017

Clinical Management of Congenital Hypogonadotropic Hypogonadism

artículo científico publicado en 2019

Computed Tomography of the Anterior Skull Base in Kallmann Syndrome Reveals Specific Ethmoid Bone Abnormalities Associated With Olfactory Bulb Defects ⬇️

artículo científico publicado el 24 de enero de 2013

Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions

artículo científico publicado en 2014

Contrôle de l’axe gonadotrope : nouveaux aspects physiologiques et thérapeutiques: Control of the gonadotrope axis: new physiologic and therapeutic aspects

scientific article published on 01 October 2017

Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism

scientific article published on 30 April 2010

Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment

scientific article published on 04 May 2011

GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing.

artículo científico publicado en 2018

Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.

artículo científico publicado en 2008

Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea

artículo científico publicado en 2014

Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients

artículo científico publicado en 2013

Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study.

artículo científico publicado en 2015

Male acquired hypogonadotropic hypogonadism: diagnosis and treatment.

artículo científico publicado en 2012

National acromegaly registries

scientific article published on 06 March 2019

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

artículo científico publicado en 2011

No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly

artículo científico publicado en 2012

Pituitary function and morphology in Fabry disease.

artículo científico publicado en 2015

Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.

artículo científico publicado en 2011

Reversal of congenital hypogonadotropic hypogonadism in a man with Kallmann syndrome due to SOX10 mutation

artículo científico publicado en 2016

SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development

artículo científico publicado en 2012

Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.

artículo científico publicado en 2008

Sex Steroids, Precursors, and Metabolite Deficiencies in Men With Isolated Hypogonadotropic Hypogonadism and Panhypopituitarism: A GCMS-Based Comparative Study

artículo científico publicado en 2015

Similarities and differences in the reproductive phenotypes of women with congenital hypogonadotrophic hypogonadism caused by GNRHR mutations and women with polycystic ovary syndrome

scientific article published on 01 January 2019

The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease

artículo científico publicado en 2019

Lista de obras de Luigi Maione

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.

Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature

Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry

Clinical Management of Congenital Hypogonadotropic Hypogonadism

Computed Tomography of the Anterior Skull Base in Kallmann Syndrome Reveals Specific Ethmoid Bone Abnormalities Associated With Olfactory Bulb Defects ⬇️

Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions

Contrôle de l’axe gonadotrope : nouveaux aspects physiologiques et thérapeutiques: Control of the gonadotrope axis: new physiologic and therapeutic aspects

Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism

Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment

GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing.

Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.

Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea

Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients

Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study.

Male acquired hypogonadotropic hypogonadism: diagnosis and treatment.

National acromegaly registries

Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly

Pituitary function and morphology in Fabry disease.

Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.

Reversal of congenital hypogonadotropic hypogonadism in a man with Kallmann syndrome due to SOX10 mutation

SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development

Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.

Sex Steroids, Precursors, and Metabolite Deficiencies in Men With Isolated Hypogonadotropic Hypogonadism and Panhypopituitarism: A GCMS-Based Comparative Study

Similarities and differences in the reproductive phenotypes of women with congenital hypogonadotrophic hypogonadism caused by GNRHR mutations and women with polycystic ovary syndrome

The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease